Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden

American Journal of Clinical Pathology

Volumn 106, Issue 1, 1996, Pages 107-111

  Zehnder, James L ^a   Benson, Renee C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Factor V Leiden; Receiver operating characteristics; Resistance to activated protein C; Test methodology; Test utility; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ARTICLE; ASSAY; BLOOD CLOTTING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SCREENING; THROMBOPHILIA;

EID: 0030012684     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.1.107     Document Type: Article

References (21)

1. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989;264:4743-4746.
2. Esmon CT. Molecular events which control the protein C anticoagulant pathway. Thromb Haemost 1993;70:29-33.
3. Heijboer H, Brandjes D, Buller HR, Sturk A, ten Gate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Med 1990;323: 1512-1516.
4. Svennson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-522.
5. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-1008.
6. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
7. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994;343:1362-1363.
8. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet 1993;342:1503-1506.
9. Voorberg J, Roelse J, Koopman R, et al. Association of idiopathic thromboembolism with a single point mutation at Arg506 of factor V. Lancet 1994;343:1535-1536.
10. Zoller B, Dahlback B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994;343:1536-1538.
11. Dahlback B. New molecular insights into the genetics of thrombophilia: Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 1995;74:139-148.
12. Takamiya O, Ishida F, Kodaira H, Kiyoshi K. APC resistance and Mnl I genotype of coagulation factor V are rare in Japanese population. Thromb Haemost 1995;74:996.
13. Rodgers GM. Activated protein C resistance and inherited thrombosis. Am J Clin Path 1994;103:261-262.
14. de Ronde H, Bertina RM. Laboratory diagnosis of APC resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994;72:880-886.
15. Rosen S, Johansson K, Lindberg K, Dahlback B. Multicenter evaluation of a kit for activated protein C resistance using plasmas from healthy individuals. Thromb Haemost 1994;72:255-260.
16. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-1293.
17. Zweig MH. ROC analysis: Assessment of diagnostic accuracy in the laboratory. Lab Med 1991;22:708-711.
18. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577.
19. Le DT, Griffin JH, Greengard JS, Mujumdar V, Rapaport SI. Use of a generally applicable tissue factor-dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. Blood 1995;85:1704-1711.
20. Tosetto A, Rodeghiero F. Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thromb Haemost 1995;73:732-733.
21. Andersson N-E, Andersson M, Andras M, Rosen S. High discrimination for FVQ506 also in OAC patients, with Coatest APC resistance after predilution in FV-deficient plasma. Blood 1995;86:912a (Abstr).